The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA)

Philip Kam-Tao Li,Marc Dorval,David W. Johnson,Pa Rutherford,Evgeny Shutov,Ken Story,Joanne M. Bargman

The Benefit of a Glucose-Sparing PD Therapy on Glycemic Control Measured by Serum Fructosamine in Diabetic Patients in a Randomized, Controlled Trial (IMPENDIA)

2015

Philip Kam-Tao Li
Marc Dorval
David W. Johnson
Pa Rutherford
Evgeny Shutov
Ken Story
Joanne M. Bargman

Background/Aims: Poor glycemic control can lead to increased morbidity and mortality in peritoneal dialysis (PD) patients. Serum fructosamine may be a more reliab

Keywords:

Randomized controlled trial
Poor glycemic control
Endocrinology
Internal medicine
Glycemic
Diabetes mellitus
Fructosamine
Peritoneal dialysis
Medicine
Regimen
Serum albumin
Confidence interval

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations